Silenseed is utilizing its proprietary LODER platform to enable treatment of cancers triggered by previously “undruggable” proteins. The LODER Platform, with its local and continuous drug delivery properties, provides a safe and effective strategy that can be applied to the treatment of different types of solid tumors.